BRAINCOOL AB (5YL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BRAINCOOL AB (5YL) has a cash flow conversion efficiency ratio of -0.135x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-23.69 Million ≈ $-27.70 Million USD) by net assets (€175.80 Million ≈ $205.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BRAINCOOL AB - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how BRAINCOOL AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BRAINCOOL AB debt and liabilities for a breakdown of total debt and financial obligations.
BRAINCOOL AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BRAINCOOL AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Invoicery Group AB
ST:FRILAN
|
0.723x |
|
NanoViricides Inc
NYSE MKT:NNVC
|
-0.222x |
|
Zee Learn Limited
NSE:ZEELEARN
|
0.432x |
|
Premier Foods PLC
LSE:PFD
|
0.024x |
|
Jui Li Enterprise Co Ltd
TW:1512
|
0.012x |
|
Hua Yang Bhd
KLSE:5062
|
-0.100x |
|
TAS Offshore Bhd
KLSE:5149
|
0.143x |
|
Duta Anggada Realty Tbk
JK:DART
|
-0.001x |
Annual Cash Flow Conversion Efficiency for BRAINCOOL AB (2021–2025)
The table below shows the annual cash flow conversion efficiency of BRAINCOOL AB from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see 5YL company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €175.80 Million ≈ $205.53 Million |
€-52.68 Million ≈ $-61.58 Million |
-0.300x | +30.19% |
| 2024-12-31 | €145.93 Million ≈ $170.61 Million |
€-62.64 Million ≈ $-73.23 Million |
-0.429x | +21.58% |
| 2023-12-31 | €111.74 Million ≈ $130.63 Million |
€-61.16 Million ≈ $-71.50 Million |
-0.547x | -37.50% |
| 2022-12-31 | €116.23 Million ≈ $135.89 Million |
€-46.27 Million ≈ $-54.09 Million |
-0.398x | +25.74% |
| 2021-12-31 | €45.23 Million ≈ $52.88 Million |
€-24.25 Million ≈ $-28.35 Million |
-0.536x | -- |
About BRAINCOOL AB
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powe… Read more